Kopek N - Search Results

1

Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.

Boily G, Filion É, Rakovich G, Kopek N, Tremblay L, Samson B, Goulet S, Roy I; Comité de l’évolution des pratiques en oncologie. Boily G, et al. Among authors: kopek n. J Thorac Oncol. 2015 Jun;10(6):872-82. doi: 10.1097/JTO.0000000000000524. J Thorac Oncol. 2015. PMID: 26001140 Free article. Review.

2

Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.

Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. Kopek N, et al. Radiother Oncol. 2009 Dec;93(3):402-7. doi: 10.1016/j.radonc.2009.06.002. Epub 2009 Jun 24. Radiother Oncol. 2009. PMID: 19559492 Clinical Trial.

3

Thoracic irradiation in 3weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?

Turgeon GA, Souhami L, Kopek N, Hirsh V, Ofiara L, Faria SL. Turgeon GA, et al. Among authors: kopek n. Cancer Radiother. 2017 Apr;21(2):89-98. doi: 10.1016/j.canrad.2016.09.015. Epub 2017 Mar 18. Cancer Radiother. 2017. PMID: 28325618 Review.

4

Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.

Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N. Guilbault C, et al. Among authors: kopek n. Clin Lung Cancer. 2017 Sep;18(5):565-571. doi: 10.1016/j.cllc.2017.02.003. Epub 2017 Mar 1. Clin Lung Cancer. 2017. PMID: 28344046 Free article.

5

Phase II trial of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer.

Faria S, Kopek N, Hijal T, Liberman S, Charlebois P, Stein B, Meterissian S, Meguerditchian A, Fawaz Z, Artho G. Faria S, et al. Among authors: kopek n. Colorectal Dis. 2014 Feb;16(2):O66-70. doi: 10.1111/codi.12466. Colorectal Dis. 2014. PMID: 24148225 Clinical Trial.

6

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.

Bossé D, Ng T, Ahmad C, Alfakeeh A, Alruzug I, Biagi J, Brierley J, Chaudhury P, Cleary S, Colwell B, Cripps C, Dawson LA, Dorreen M, Ferland E, Galiatsatos P, Girard S, Gray S, Halwani F, Kopek N, Mahmud A, Martel G, Robillard L, Samson B, Seal M, Siddiqui J, Sideris L, Snow S, Thirwell M, Vickers M, Goodwin R, Goel R, Hsu T, Tsvetkova E, Ward B, Asmis T. Bossé D, et al. Among authors: kopek n. Curr Oncol. 2016 Dec;23(6):e605-e614. doi: 10.3747/co.23.3394. Epub 2016 Dec 21. Curr Oncol. 2016. PMID: 28050151 Free PMC article.

7

Stereotactic radiation therapy for residual chemorefractory primary mediastinal non-seminomatous germ cell tumor after surgical thoracotomy.

Laflamme P, Doucet C, Sirois C, Kopek N, Vanhuyse M. Laflamme P, et al. Among authors: kopek n. Pract Radiat Oncol. 2017 Jul-Aug;7(4):260-263. doi: 10.1016/j.prro.2017.01.004. Epub 2017 Jan 7. Pract Radiat Oncol. 2017. PMID: 28222996 No abstract available.

8

Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression.

Pembroke CA, Fortin B, Kopek N. Pembroke CA, et al. Among authors: kopek n. Radiother Oncol. 2018 Jun;127(3):493-500. doi: 10.1016/j.radonc.2018.04.022. Epub 2018 May 4. Radiother Oncol. 2018. PMID: 29735409

9

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

Olson R, Senan S, Harrow S, Gaede S, Louie A, Haasbeek C, Mulroy L, Lock M, Rodrigues G, Yaremko B, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman G, Warner A, Palma D. Olson R, et al. Among authors: kopek n. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):943-947. doi: 10.1016/j.ijrobp.2019.08.041. Epub 2019 Aug 27. Int J Radiat Oncol Biol Phys. 2019. PMID: 31470091 Clinical Trial.

10

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.

Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Schlijper R, Bauman GS, Laba J, Qu XM, Warner A, Senan S. Palma DA, et al. Among authors: kopek n. J Clin Oncol. 2020 Sep 1;38(25):2830-2838. doi: 10.1200/JCO.20.00818. Epub 2020 Jun 2. J Clin Oncol. 2020. PMID: 32484754 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page